Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INC | Chief Innovation Officer | Class A common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
REATA PHARMACEUTICALS INC | Chief Innovation Officer | Class B common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
REATA PHARMACEUTICALS INC | Chief Innovation Officer | Employee Stock Option (right to buy) | 0 | Sep 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RETA | REATA PHARMACEUTICALS INC | Sep 26, 2023 | 12 | $0 | 4 | Sep 26, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Aug 15, 2023 | 2 | -$463K | 4 | Aug 17, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Jul 6, 2023 | 1 | $0 | 4 | Jul 10, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | May 15, 2023 | 3 | -$527K | 4 | May 17, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Mar 7, 2023 | 1 | -$52.5K | 4 | Mar 8, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Mar 2, 2023 | 10 | -$7.17M | 4 | Mar 6, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Feb 28, 2023 | 2 | $0 | 4 | Mar 1, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Chief Innovation Officer |
RETA | REATA PHARMACEUTICALS INC | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Chief Research Officer |
RETA | REATA PHARMACEUTICALS INC | Jun 14, 2021 | 16 | -$8.33M | 4 | Jun 16, 2021 | Chief Research Officer |